COMP <GO>
PETS vs COST // RETURN ON INVESTED CAPITAL (ROIC)
PetMed Express Inc. (NASDAQ) VS. Costco Wholesale Corporation (NASDAQ) • 15-METRIC TALLY: PETS 1
— COST 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: COST
LAST: $1.18 (-0.84%) • MKT CAP: $25.6M
roic
-35.00%
LAST: $996.08 (+1.36%) • MKT CAP: $441.39B
roic
42.43%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PETS VS. COST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PETS | COST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.10% | 12.82% | +15.28 | PETS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 42.43% | -77.43 | COST | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.09% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -32.80% | 3.85% | -36.65 | COST | /operating-margins <GO> |
| Net Profit Margin | -32.00% | 3.04% | -35.04 | COST | /net-margins <GO> |
| Revenue Growth (YoY) | -21.10% | 10.14% | -31.24 | COST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.08% | 0.58% | -0.50 | COST | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.24 | 9.38 | -9.14 | COST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 6/9 | -4.00 | COST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.46% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.1 | 57.7 | -23.59 | COST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.73 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 39.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $25.6M | $441.39B | -$441.37B | COST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PETS REV | COST REV | PETS GROSS % | COST GROSS % | PETS FCF | COST FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $303.15B | — | 12.8% | — | $9.38B |
| FY 2025 | $179.0M | $275.24B | 28.1% | 12.8% | -$33.0M | $7.84B |
| FY 2024 | $227.0M | $254.45B | 30.5% | 12.6% | -$395.0K | $6.63B |
| FY 2023 | $274.1M | $242.29B | — | 12.3% | $4.3M | $6.75B |
| FY 2022 | — | $226.95B | — | 12.2% | — | $3.50B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PETS // BETA —
COST // BETA 0.73